Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from ovarian cancer, peritoneal mesothelioma, or abdominal sarcoma
Record ID 32010000862
English
Authors' objectives:
Intraperitoneal hyperthermic chemotherapy (IPHC) is used as an adjunct to surgery for the treatment of gastrointestinal, appendiceal, ovarian, or mesothelial cancers that have metastasized or may metastasize into the peritoneal cavity. Chemotherapeutic drugs are introduced directly into the peritoneal space to eliminate microscopic tumor on the peritoneal lining and the outer surfaces of affected organs and to kill tumor cells that have disseminated throughout the cavity. Heating enhances the cytotoxic effect of the drugs.
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Mesothelioma
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Sarcoma
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2009 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.